Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

21.25

-0.17 (-0.79%)

Oct 26, 2026, 9:40 AM EDT - Market open

Anika Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	120.65	112.82	119.91	120.79	113.83	147.79
Revenue Growth	5.33%	-5.91%	-0.73%	6.12%	-22.98%	13.29%
Gross Profit	75	63.81	76.6	82.53	73.22	89.41
Operating Income	-2.59	-11.05	-4.5	0.84	3.67	-12.02
Net Income	-3.78	-10.88	-56.39	-82.67	-14.86	4.13
Earnings Per Share	-0.28	-0.76	-3.83	-5.64	-1.02	0.28
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	74.11	70.06	82.45	86.91	83.75	113.83
Europe	25.17	22.21	19.4	17.31	17.23	19.58
Other	21.38	20.55	18.06	16.57	12.85	14.38
Total	120.65	112.82	119.91	120.79	113.83	147.79

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	38.41	57.48	55.63	68.74	86.33	94.39
Total Debt	25.25	26.25	25.93	27.74	30.89	20.95
Net Cash (Debt)	13.16	31.23	29.7	41	55.44	73.43
Net Cash Growth	-53.29%	5.17%	-27.57%	-26.05%	-24.51%	-3.19%
Net Cash Per Share	0.95	2.18	2.02	2.80	3.81	5.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	5.98	11.19	5.4	-1.79	4.41	8.4
Capital Expenditures	-5.42	-6.83	-7.73	-5.43	-7.49	-5.14
Free Cash Flow	0.56	4.36	-2.33	-7.22	-3.08	3.25
Free Cash Flow Growth	-	-	-	-	-	-71.55%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	62.17%	56.56%	63.89%	68.33%	64.33%	60.49%
Operating Margin	-2.15%	-9.79%	-3.75%	0.70%	3.22%	-8.13%
Pretax Margin	-2.41%	-8.25%	-2.31%	2.61%	3.80%	1.64%
Profit Margin	-3.14%	-9.64%	-47.02%	-68.44%	-13.05%	2.80%
FCF Margin	0.47%	3.87%	-1.94%	-5.97%	-2.70%	2.20%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	125.13
Forward PE	23.88	53.39	39.19	72.08	72.08	112.55
P/FCF Ratio	510.08	31.77	-	-	-	158.96
PS Ratio	2.38	1.23	2.01	2.75	3.80	3.50